$1.05
2.86%
Downside
Day's Volatility :7.27%
Upside
4.55%
51.43%
Downside
52 Weeks Volatility :92.03%
Upside
83.59%
Period | Mira Pharmaceuticals Inc | Index (Russel 2000) |
---|---|---|
3 Months | 44.59% | 0.0% |
6 Months | 28.92% | 0.0% |
1 Year | -62.72% | 0.0% |
3 Years | -85.58% | -21.9% |
Market Capitalization | 17.7M |
Book Value | $0.15 |
Earnings Per Share (EPS) | -0.86 |
Wall Street Target Price | 11.67 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -177.53% |
Return On Equity TTM | -748.59% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -0.86 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.56 |
EPS Estimate Next Year | -0.49 |
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Next Quarter | -0.16 |
What analysts predicted
Upside of 1011.43%
Sell
Neutral
Buy
Mira Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Mira Pharmaceuticals Inc | -16.41% | 28.92% | -62.72% | -85.58% | -85.58% |
Eli Lilly And Company | 0.65% | 23.81% | 50.74% | 290.75% | 747.32% |
Johnson & Johnson | -3.23% | 9.49% | 2.58% | 0.19% | 21.65% |
Merck & Co. Inc. | -7.01% | -13.08% | 5.33% | 40.04% | 28.99% |
Abbvie Inc | -0.04% | 21.02% | 32.89% | 78.95% | 162.62% |
Amgen Inc. | -3.17% | 22.26% | 13.16% | 56.19% | 58.61% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Mira Pharmaceuticals Inc | NA | NA | NA | -0.56 | -7.49 | -1.78 | NA | 0.15 |
Eli Lilly And Company | 114.9 | 114.9 | 0.88 | 16.39 | 0.59 | 0.14 | 0.01 | 15.06 |
Johnson & Johnson | 24.45 | 24.45 | 0.95 | 9.84 | 0.22 | 0.08 | 0.03 | 29.72 |
Merck & Co. Inc. | 20.31 | 20.31 | 0.08 | 7.92 | 0.33 | 0.11 | 0.03 | 17.19 |
Abbvie Inc | 64.95 | 64.95 | 0.46 | 10.86 | 0.54 | 0.08 | 0.03 | 3.84 |
Amgen Inc. | 55.87 | 55.87 | 2.29 | 19.49 | 0.49 | 0.04 | 0.03 | 11.03 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Mira Pharmaceuticals Inc | NA | $17.7M | -85.58% | NA | 0.0% |
Eli Lilly And Company | Buy | $839.3B | 747.32% | 114.9 | 18.86% |
Johnson & Johnson | Buy | $389.0B | 21.65% | 24.45 | 43.91% |
Merck & Co. Inc. | Buy | $278.1B | 28.99% | 20.31 | 21.99% |
Abbvie Inc | Buy | $343.0B | 162.62% | 64.95 | 9.71% |
Amgen Inc. | Buy | $176.4B | 58.61% | 55.87 | 10.12% |
Insights on Mira Pharmaceuticals Inc
In the last 1 year, Eli Lilly And Company has given 52.6% return, outperforming this stock by 115.3%
Organization | Mira Pharmaceuticals Inc |
Employees | 0 |
CEO | Mr. Erez Aminov |
Industry | Miscellaneous |
Kraneshares Msci China All Shares Index Etf
$1.05
-1.87%
Xtrs Low Beta Hi Yield Etf
$1.05
-1.87%
Pmv Adaptive Risk Parity Etf
$1.05
-1.87%
Hitek Global Inc
$1.05
-1.87%
Arrow Dwa Country Rotation Etf -
$1.05
-1.87%
Oneascent Core Plus Bond Etf
$1.05
-1.87%
Short Dow30 Proshares
$1.05
-1.87%
Multimetaverse Holdings Limited
$1.05
-1.87%
Lakeside Holding Ltd.
$1.05
-1.87%